Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pharmacotherapy. 2003 Mar;23(3):339-48.

Pleconaril, a novel antipicornaviral agent.

Author information

  • 1Department of Pharmacy Research, Hartford Hospital, Hartford, Connecticut 06102, USA.

Abstract

Despite the availability of therapy for selected symptoms, no specific antiviral agents are available to treat or prevent infections due to the viruses of the Picornaviridae family--rhinoviruses and enteroviruses. Characterization of the three-dimensional structure of picornaviruses in the 1980s allowed development of compounds targeted at the virus itself. Pleconaril is a novel, orally available, systemically acting molecule whose pharmacokinetics are characterized by a two-compartment open model with first-order absorption and with a safety profile similar to that of placebo. It shows promising results in treatment of picornaviral respiratory tract infections, meningitis, and other life-threatening infections.

PMID:
12627933
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk